{"id":"https://openalex.org/W4394599724","doi":"https://doi.org/10.1212/wnl.0000000000206359","title":"Healthcare Utilization and Persistence in Patients with Dravet Syndrome: A Retrospective Analysis Using U.S. Claims Data (P1-1.003)","display_name":"Healthcare Utilization and Persistence in Patients with Dravet Syndrome: A Retrospective Analysis Using U.S. Claims Data (P1-1.003)","publication_year":2024,"publication_date":"2024-04-09","ids":{"openalex":"https://openalex.org/W4394599724","doi":"https://doi.org/10.1212/wnl.0000000000206359"},"language":"en","primary_location":{"id":"doi:10.1212/wnl.0000000000206359","doi":"https://doi.org/10.1212/wnl.0000000000206359","is_oa":false,"landing_page_url":"https://doi.org/10.1212/wnl.0000000000206359","pdf_url":null,"source":{"id":"https://openalex.org/S79704628","display_name":"Neurology","issn_l":"0028-3878","issn":["0028-3878","1526-632X"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-a","doyens","jufo-3","ki-jl-2","medline","norway-2","poland-140","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310315671","host_organization_name":"Lippincott Williams & Wilkins","host_organization_lineage":["https://openalex.org/P4310315671","https://openalex.org/P4310318547"],"host_organization_lineage_names":["Lippincott Williams & Wilkins","Wolters Kluwer"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Neurology","raw_type":"journal-article"},"volume":null,"type":"article","is_traditional":true,"indexed_in":["crossref"],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5076372579","display_name":"Srihari Jaganathan","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Srihari Jaganathan","raw_affiliation_strings":["UCB, Inc"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"UCB, Inc","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5051894251","display_name":"Derek Ems","orcid":"https://orcid.org/0009-0001-7878-615X","observed_orcids":["https://orcid.org/0009-0001-7878-615X"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Derek Ems","raw_affiliation_strings":["UCB, Inc"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"UCB, Inc","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5092862230","display_name":"Rob Sederman","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Rob Sederman","raw_affiliation_strings":["Ambit Inc"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Ambit Inc","institution_ids":[]}]},{"author_position":"middle","author":{"id":null,"display_name":"Chen Chen","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Chen Chen","raw_affiliation_strings":["Ambit Inc"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Ambit Inc","institution_ids":[]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5051612887","display_name":"Shuang Wu","orcid":"https://orcid.org/0000-0001-7236-6819","observed_orcids":["https://orcid.org/0000-0001-7236-6819"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Shuang Wu","raw_affiliation_strings":["Ambit Inc"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Ambit Inc","institution_ids":[]}]}],"institutions":[],"countries_distinct_count":0,"institutions_distinct_count":0,"corresponding_author_ids":[],"corresponding_institution_ids":[],"apc_list":null,"apc_paid":null,"fwci":0.2595,"has_fulltext":false,"cited_by_count":1,"citation_normalized_percentile":{"value":0.49020093,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":{"min":92,"max":95},"biblio":{"volume":"102","issue":"7_supplement_1","first_page":null,"last_page":null},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10094","display_name":"Epilepsy research and treatment","score":0.9911999702453613,"subfield":{"id":"https://openalex.org/subfields/2728","display_name":"Clinical Neurology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T10094","display_name":"Epilepsy research and treatment","score":0.9911999702453613,"subfield":{"id":"https://openalex.org/subfields/2728","display_name":"Clinical Neurology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T12229","display_name":"Pharmacological Effects and Toxicity Studies","score":0.0012000000569969416,"subfield":{"id":"https://openalex.org/subfields/2735","display_name":"Pediatrics, Perinatology and Child Health"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T12267","display_name":"Diet and metabolism studies","score":0.0006000000284984708,"subfield":{"id":"https://openalex.org/subfields/2737","display_name":"Physiology (medical)"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/dravet-syndrome","display_name":"Dravet syndrome","score":1.0},{"id":"https://openalex.org/keywords/fenfluramine","display_name":"fenfluramine","score":0.9940000176429749},{"id":"https://openalex.org/keywords/medication-persistence","display_name":"treatment persistence","score":0.8960000276565552},{"id":"https://openalex.org/keywords/health-care-utilization","display_name":"health care utilization","score":0.9810000061988831},{"id":"https://openalex.org/keywords/antiepileptic-drugs","display_name":"antiepileptic drugs","score":0.6690000295639038},{"id":"https://openalex.org/keywords/claims-data","display_name":"claims data","score":0.5149999856948853}],"concepts":[{"id":"https://openalex.org/C2780623815","wikidata":"https://www.wikidata.org/wiki/Q1255956","display_name":"Dravet syndrome","level":3,"score":0.9913517236709595},{"id":"https://openalex.org/C2781009140","wikidata":"https://www.wikidata.org/wiki/Q7170389","display_name":"Persistence (discontinuity)","level":2,"score":0.861329197883606},{"id":"https://openalex.org/C2779638493","wikidata":"https://www.wikidata.org/wiki/Q418928","display_name":"Fenfluramine","level":4,"score":0.7457894682884216},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.5450451970100403},{"id":"https://openalex.org/C2778186239","wikidata":"https://www.wikidata.org/wiki/Q41571","display_name":"Epilepsy","level":2,"score":0.46652090549468994},{"id":"https://openalex.org/C160735492","wikidata":"https://www.wikidata.org/wiki/Q31207","display_name":"Health care","level":2,"score":0.45714500546455383},{"id":"https://openalex.org/C187212893","wikidata":"https://www.wikidata.org/wiki/Q123028","display_name":"Pediatrics","level":1,"score":0.443962961435318},{"id":"https://openalex.org/C177713679","wikidata":"https://www.wikidata.org/wiki/Q679690","display_name":"Intensive care medicine","level":1,"score":0.327020525932312},{"id":"https://openalex.org/C118552586","wikidata":"https://www.wikidata.org/wiki/Q7867","display_name":"Psychiatry","level":1,"score":0.2371804416179657},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.2145862877368927},{"id":"https://openalex.org/C162324750","wikidata":"https://www.wikidata.org/wiki/Q8134","display_name":"Economics","level":0,"score":0.1321968138217926},{"id":"https://openalex.org/C127413603","wikidata":"https://www.wikidata.org/wiki/Q11023","display_name":"Engineering","level":0,"score":0.0},{"id":"https://openalex.org/C170493617","wikidata":"https://www.wikidata.org/wiki/Q208467","display_name":"Receptor","level":2,"score":0.0},{"id":"https://openalex.org/C187320778","wikidata":"https://www.wikidata.org/wiki/Q1349130","display_name":"Geotechnical engineering","level":1,"score":0.0},{"id":"https://openalex.org/C2775864247","wikidata":"https://www.wikidata.org/wiki/Q167934","display_name":"Serotonin","level":3,"score":0.0},{"id":"https://openalex.org/C50522688","wikidata":"https://www.wikidata.org/wiki/Q189833","display_name":"Economic growth","level":1,"score":0.0}],"mesh":[],"locations_count":1,"locations":[{"id":"doi:10.1212/wnl.0000000000206359","doi":"https://doi.org/10.1212/wnl.0000000000206359","is_oa":false,"landing_page_url":"https://doi.org/10.1212/wnl.0000000000206359","pdf_url":null,"source":{"id":"https://openalex.org/S79704628","display_name":"Neurology","issn_l":"0028-3878","issn":["0028-3878","1526-632X"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-a","doyens","jufo-3","ki-jl-2","medline","norway-2","poland-140","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310315671","host_organization_name":"Lippincott Williams & Wilkins","host_organization_lineage":["https://openalex.org/P4310315671","https://openalex.org/P4310318547"],"host_organization_lineage_names":["Lippincott Williams & Wilkins","Wolters Kluwer"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Neurology","raw_type":"journal-article"}],"best_oa_location":null,"sustainable_development_goals":[{"display_name":"Good health and well-being","score":1.0,"id":"https://metadata.un.org/sdg/3"}],"study_designs":[{"display_name":"Observational Study","id":"https://openalex.org/study-designs/observational-study"}],"awards":[],"funders":[],"has_content":{"pdf":false,"grobid_xml":false},"content_urls":null,"referenced_works_count":0,"referenced_works":[],"related_works":["https://openalex.org/W7164838575","https://openalex.org/W4409226735","https://openalex.org/W2399319535","https://openalex.org/W1926532831","https://openalex.org/W3189742141","https://openalex.org/W3113909170","https://openalex.org/W4408362450","https://openalex.org/W4405891535","https://openalex.org/W7203964192","https://openalex.org/W4415496284"],"abstract_inverted_index":{"Objective:":[0],"To":[1],"understand":[2],"medication":[3,72,86,125],"persistence":[4,73,173,190],"associated":[5],"with":[6,23,100,108,177,234,286,289],"the":[7,13,121,154,161],"use":[8,88,110,168,251],"of":[9,53,111,123,130,165,321,342],"fenfluramine":[10,16,156,167,181,196,239,290,295],"and":[11,17,35,47,50,55,76,81,89,137,185,270,303],"quantify":[12],"relationship":[14],"between":[15,142,149],"seizure-related":[18],"healthcare":[19,65,82,90,280],"events":[20],"in":[21,59,248,279,328,348],"patients":[22],"Dravet":[24],"syndrome":[25],"(DS),":[26],"using":[27],"claims":[28,66],"data.":[29],"Background:":[30],"DS":[31,101,178,287],"is":[32],"a":[33,63,128,246,297],"rare":[34],"lifelong":[36],"developmental":[37],"epileptic":[38],"encephalopathy":[39],"marked":[40],"by":[41,104],"treatment-resistant":[42],"seizures,":[43],"significant":[44],"developmental,":[45],"motor,":[46],"behavioral":[48],"impairments,":[49],"increased":[51],"risk":[52],"mortality":[54],"sudden":[56],"unexpected":[57],"death":[58],"epilepsy.":[60],"Design/Methods:":[61],"Komodo,":[62],"US":[64],"database,":[67],"was":[68,118,169,198,211,229,245],"used":[69,180,238],"to":[70,153,160,214,301,354,360,366],"measure":[71],"vs":[74],"valproate":[75,183,205,218,302],"levetiracetam":[77,186,208,223],"over":[78,96],"12":[79],"months,":[80],"utilization":[83,281],"(rescue":[84],"anti-seizure":[85],"[ASM]":[87],"visits":[91,256,261,266],"[ER,":[92],"outpatient,":[93],"neurology,":[94],"inpatient])":[95],"6":[97,150,163],"months.":[98,243,293],"Individuals":[99,107],"were":[102,115,145,282],"identified":[103],"ICD-10":[105],"codes.":[106],"prior/concomitant":[109],"cannabidiol":[112],"or":[113,207,222],"stiripentol":[114],"excluded.":[116],"Persistence":[117],"defined":[119],"as":[120,318,339],"duration":[122],"continuous":[124,166],"supply":[126],"without":[127],"gap":[129],">90":[131],"days.":[132],"Kaplan-Meier":[133],"survival":[134],"analysis":[135,174],"(estimate)":[136],"log-rank":[138],"tests":[139],"(persistence":[140],"rates":[141],"treatment":[143],"groups)":[144],"used.":[146],"Percentage":[147],"change":[148],"months":[151,164],"prior":[152],"first":[155,162],"prescription":[157],"claim":[158],"(\u201cPre\u201d)":[159],"measured.":[170],"Results:":[171],"The":[172,188],"included":[175],"individuals":[176,193,233,285],"who":[179,194,203],"(n=374),":[182],"(n=484),":[184],"(n=603).":[187],"12-month":[189],"rate":[191],"for":[192,201,231,241,291,316,337],"initiated":[195,204],"(66%)":[197],"higher":[199],"than":[200,217],"those":[202],"(34%)":[206],"(36%).":[209],"Fenfluramine":[210],"more":[212],"likely":[213],"be":[215],"persistent":[216],"(":[219,224],"p":[220],"<0.001)":[221],"P":[225,253,258,263,268,274],"<0.001).":[226],"Pre":[227],"data":[228],"available":[230],"108":[232],"DS;":[235],"91":[236],"(84%)":[237],"continuously":[240],"\u22656":[242,292],"There":[244],"reduction":[247],"rescue":[249],"ASM":[250],"(77%,":[252],"<0.001),":[254],"ER":[255],"(50%,":[257],"=0.013),":[259],"outpatient":[260],"(27%,":[262],"=0.009),":[264],"neurology":[265],"(24%,":[267,273],"=0.07)":[269],"inpatient":[271],"hospitalizations":[272],"=0.39).":[275],"Conclusions:":[276],"Meaningful":[277],"reductions":[278],"seen":[283],"among":[284],"treated":[288],"Further,":[294],"demonstrates":[296],"strong":[298],"persistency":[299],"compared":[300],"levetiracetam,":[304],"suggesting":[305],"improved":[306],"long-term":[307],"outcomes.":[308],"Disclosure:":[309],"Mr.":[310,324,331,344,350],"Jaganathan":[311,325],"has":[312,326,333,346,352,358,364],"received":[313,334],"personal":[314,335],"compensation":[315,336],"serving":[317,338],"an":[319,340],"employee":[320,341],"UCB,":[322,329],"Inc.":[323,330],"stock":[327,347],"Ems":[332,345],"UCB.":[343,349],"Sederman":[351],"nothing":[353,359,365],"disclose.":[355,361,367],"Ms.":[356],"Chen":[357],"Shuang":[362],"Wu":[363]},"counts_by_year":[{"year":2026,"cited_by_count":1}],"updated_date":"2026-11-04T10:54:05.112534","created_date":"2024-04-10T00:00:00"}